282 related articles for article (PubMed ID: 21635718)
1. Regulation of bone by the adaptive immune system in arthritis.
Okamoto K; Takayanagi H
Arthritis Res Ther; 2011 May; 13(3):219. PubMed ID: 21635718
[TBL] [Abstract][Full Text] [Related]
2. Osteoimmunology.
Okamoto K; Takayanagi H
Cold Spring Harb Perspect Med; 2019 Jan; 9(1):. PubMed ID: 29610150
[TBL] [Abstract][Full Text] [Related]
3. The immune cells in modulating osteoclast formation and bone metabolism.
Hong J; Luo F; Du X; Xian F; Li X
Int Immunopharmacol; 2024 May; 133():112151. PubMed ID: 38685175
[TBL] [Abstract][Full Text] [Related]
4. Osteoimmunology: cytokines and the skeletal system.
Lee SH; Kim TS; Choi Y; Lorenzo J
BMB Rep; 2008 Jul; 41(7):495-510. PubMed ID: 18682033
[TBL] [Abstract][Full Text] [Related]
5. Bone-immune cell crosstalk: bone diseases.
Mori G; D'Amelio P; Faccio R; Brunetti G
J Immunol Res; 2015; 2015():108451. PubMed ID: 26000310
[TBL] [Abstract][Full Text] [Related]
6. Osteoimmunology in rheumatic diseases.
Schett G
Arthritis Res Ther; 2009; 11(1):210. PubMed ID: 19232069
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints.
Komatsu N; Takayanagi H
Front Immunol; 2012; 3():77. PubMed ID: 22566958
[TBL] [Abstract][Full Text] [Related]
8. Trends in Treatment, Outcomes, and Incidence of Orthopedic Surgery in Patients with Rheumatoid Arthritis: An Observational Cohort Study Using the Japanese National Database of Rheumatic Diseases.
Matsumoto T; Nishino J; Izawa N; Naito M; Hirose J; Tanaka S; Yasui T; Saisho K; Tohma S
J Rheumatol; 2017 Nov; 44(11):1575-1582. PubMed ID: 28864641
[TBL] [Abstract][Full Text] [Related]
9. What are super-enhancers?
Pott S; Lieb JD
Nat Genet; 2015 Jan; 47(1):8-12. PubMed ID: 25547603
[TBL] [Abstract][Full Text] [Related]
10. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.
Traves PG; Murray B; Campigotto F; Galien R; Meng A; Di Paolo JA
Ann Rheum Dis; 2021 Jul; 80(7):865-875. PubMed ID: 33741556
[TBL] [Abstract][Full Text] [Related]
11. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
Fujimori K; Tarasawa K; Fushimi K
Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of peroneal nerve functional electrical stimulation in chronic stroke patients with hemiplegia (PLEASURE): A multicentre, prospective, randomised controlled trial.
Hachisuka K; Ochi M; Kikuchi T; Saeki S
Clin Rehabil; 2021 Mar; 35(3):367-377. PubMed ID: 33103916
[TBL] [Abstract][Full Text] [Related]
13. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328
[TBL] [Abstract][Full Text] [Related]
14. Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
Genovese MC; Kalunian K; Gottenberg JE; Mozaffarian N; Bartok B; Matzkies F; Gao J; Guo Y; Tasset C; Sundy JS; de Vlam K; Walker D; Takeuchi T
JAMA; 2019 Jul; 322(4):315-325. PubMed ID: 31334793
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate.
Fleischmann R; Takeuchi T; Schiff M; Schlichting D; Xie L; Issa M; Stoykov I; Lisse J; Martinez-Osuna P; Rooney T; Zerbini CAF
Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1112-1121. PubMed ID: 31233281
[TBL] [Abstract][Full Text] [Related]
16. Follicle-Stimulating Hormone Glycobiology.
Bousfield GR; Harvey DJ
Endocrinology; 2019 Jun; 160(6):1515-1535. PubMed ID: 31127275
[TBL] [Abstract][Full Text] [Related]
17. Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan.
Tanaka Y; Wada K; Takahashi Y; Hagino O; van Hoogstraten H; Graham NMH; Kameda H
Arthritis Res Ther; 2019 Mar; 21(1):79. PubMed ID: 30894208
[TBL] [Abstract][Full Text] [Related]
18. The emerging safety profile of JAK inhibitors in rheumatic disease.
Winthrop KL
Nat Rev Rheumatol; 2017 Apr; 13(4):234-243. PubMed ID: 28250461
[TBL] [Abstract][Full Text] [Related]
19. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.
Pandit-Taskar N; O'Donoghue JA; Ruan S; Lyashchenko SK; Carrasquillo JA; Heller G; Martinez DF; Cheal SM; Lewis JS; Fleisher M; Keppler JS; Reiter RE; Wu AM; Weber WA; Scher HI; Larson SM; Morris MJ
J Nucl Med; 2016 Dec; 57(12):1858-1864. PubMed ID: 27516450
[TBL] [Abstract][Full Text] [Related]
20. Neurotropin attenuates local inflammatory response and inhibits demyelination induced by chronic constriction injury of the mouse sciatic nerve.
Nishimoto S; Okada K; Tanaka H; Okamoto M; Fujisawa H; Okada T; Naiki M; Murase T; Yoshikawa H
Biologicals; 2016 Jul; 44(4):206-211. PubMed ID: 27233579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
